Jean-claude Forest

Quebec, QC, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications

First-Trimester Placental Growth Factor and HELLP Syndrome: The PREDICTION Study.

First-Trimester Placental Growth Factor and HELLP Syndrome: The PREDICTION Study.

Journal: Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC
Published: March 26, 2026

A Comparison of Preeclampsia Screening Using Clinical Risk Factors and the Fetal Medicine Foundation Algorithm.

A Comparison of Preeclampsia Screening Using Clinical Risk Factors and the Fetal Medicine Foundation Algorithm.

Journal: Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC
Published: March 23, 2026

Soluble fms-Like Tyrosine Kinase-1 to Placental Growth Factor Ratio for the Prediction of Preeclampsia in Asymptomatic Women.

Soluble fms-Like Tyrosine Kinase-1 to Placental Growth Factor Ratio for the Prediction of Preeclampsia in Asymptomatic Women.

Journal: Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC
Published: January 30, 2026

Enrichment of Fetal Cell-Free DNA in Early Miscarriages for Detection of Aneuploidy: A Novel Approach.

Enrichment of Fetal Cell-Free DNA in Early Miscarriages for Detection of Aneuploidy: A Novel Approach.

Journal: Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC
Published: January 29, 2026

Differential expression of ADAM10 in fetal membranes during pregnancy and evaluation as an early blood biomarker for preterm birth.

Differential expression of ADAM10 in fetal membranes during pregnancy and evaluation as an early blood biomarker for preterm birth.

Journal: Journal of reproductive immunology
Published: October 31, 2025

Validation of PREM-PS, a patient-reported experience instrument, in a randomized controlled trial of pregnant women undergoing prenatal screening.

Validation of PREM-PS, a patient-reported experience instrument, in a randomized controlled trial of pregnant women undergoing prenatal screening.

Journal: Journal of patient-reported outcomes
Published: June 30, 2025

Prenatal Cell-Free DNA Screening With Fetal Enrichment Enables Sampling From 8 Weeks of Gestational Age.

Prenatal Cell-Free DNA Screening With Fetal Enrichment Enables Sampling From 8 Weeks of Gestational Age.

Journal: Clinical genetics
Published: May 13, 2025

Real-life implementation of prenatal cell-free DNA screening with in vitro fetal enrichment virtually eliminates the need for redraws and improves performance: A cohort study.

Real-life implementation of prenatal cell-free DNA screening with in vitro fetal enrichment virtually eliminates the need for redraws and improves performance: A cohort study.

Journal: Genetics in medicine open
Published: April 03, 2025

Assessment of pregnant women's intention to use a mobile application-based decision aid for prenatal screening for trisomies 21, 18 and 13: A mixed-methods cross-sectional study.

Assessment of pregnant women's intention to use a mobile application-based decision aid for prenatal screening for trisomies 21, 18 and 13: A mixed-methods cross-sectional study.

Journal: Patient education and counseling
Published: February 04, 2025

Reinfection With Cytomegalovirus During Pregnancy: A Prospective Cohort Study in Canada.

Reinfection With Cytomegalovirus During Pregnancy: A Prospective Cohort Study in Canada.

Journal: Journal of medical virology
Published: November 17, 2024

First-Trimester PlGF and PAPP-A and the Risk of Placenta-Mediated Complications: PREDICTION Prospective Study.

First-Trimester PlGF and PAPP-A and the Risk of Placenta-Mediated Complications: PREDICTION Prospective Study.

Journal: Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC
Published: September 16, 2024

First-Trimester Soluble fms-like Tyrosine Kinase 1 (sFlt-1) for the Prediction of Preterm Preeclampsia.

First-Trimester Soluble fms-like Tyrosine Kinase 1 (sFlt-1) for the Prediction of Preterm Preeclampsia.

Journal: Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC
Published: August 21, 2024
Showing 1-12 of 51

Last Updated: 09/26/2026